Recent trends in mental illness and omega-3 fatty acids

J Neural Transm (Vienna). 2020 Nov;127(11):1491-1499. doi: 10.1007/s00702-020-02212-z. Epub 2020 May 25.

Abstract

Although it is clear that nutrition affects physical and metabolic functions in humans, the importance of nutrition in mental illness has often been overlooked. Following a report by Hibbeln (Lancet 351:1213, 1998) published in The Lancet, which suggested that depression rates and fish consumption were inversely correlated, the relationships between a variety of nutritional/epidemiological treatments and neuropsychiatric disorders have received increased attention. In particular, many studies have been conducted on the omega-3 fatty acid mechanism of action in pathophysiological aspects of various neuropsychiatric disorders. Furthermore, many clinical studies have also been conducted on the effects of omega-3 replacement therapy. Therefore, this article reports recent trends in, and perspectives on, the use of omega-3 fatty acids to treat the five psychiatric disorders: schizophrenia (a delusion of the psychotic zone), depression and other mood disorders, attention deficit hyperactivity disorder (a developmental disorder), post-traumatic stress disorder (psychological trauma after the disaster), and Alzheimer-type dementia.

Keywords: Mental illness; Nutrition; Omega-3 polyunsaturated fatty acids; Pufas.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease*
  • Animals
  • Attention Deficit Disorder with Hyperactivity*
  • Fatty Acids, Omega-3* / therapeutic use
  • Humans
  • Mood Disorders
  • Schizophrenia*

Substances

  • Fatty Acids, Omega-3